Latest Brisbane News

Nuix has appointed John Ruthven as its permanent CEO and Managing Director, ending a global search and signalling leadership continuity following his interim role since November 2025.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.

Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.

Emyria reported $1.2 million revenue for Q1 2026 driven by insurer-funded clinics and expanded its Empax network across multiple states. It launched a Global Partnership Program targeting international drug sponsors, leveraging its clinical infrastructure amid growing global interest in psychedelic therapies.

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Venari Minerals has delivered a maiden JORC Inferred Mineral Resource Estimate for its Red Mountain Lithium Project in Nevada, revealing 3.03 million tonnes of contained Lithium Carbonate Equivalent. The company also reported improved beneficiation results and completed a share buyback to streamline its register.

Macallum New Energy has successfully listed on the ASX and raised A$7.4 million to fund exploration in the Northern Perth Basin. The company is progressing a 66% complete Barberton 3D seismic survey and preparing a Condor 2D survey, positioning itself amid renewed regional drilling activity.

Felix Group Holdings reported a 47% surge in total ARR to $12.7 million in Q3 FY26, driven by the Nexvia acquisition and enterprise expansion. The company is progressing AI platform enhancements and completed a key leadership renewal with new Chairman and CEO appointments.

Mirvac Group reported robust operational results in 3Q26, driven by a 28% jump in residential sales, high occupancy across its investment portfolio, and a successful $630 million capital raise for its wholesale office fund. The company reaffirmed its FY26 guidance amid cautious risk management.

Lion Energy has secured funding for its East Seram Bula Karang-1 exploration well, reduced capital risk by divesting its Seram (Non-Bula) PSC stake, and put green hydrogen development on hold pending commercial clarity.